Related Experiment Video
Updated: Apr 23, 2026

11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
Challenging clinical cases in HCV infection
BMC Infectious Diseases
|September 20, 2014
Summary
Diagnosing hepatitis C virus (HCV) infection presents challenges, as seen in a case where a patient delayed follow-up until developing liver cancer. Liver biopsy was crucial for diagnosis when non-invasive methods failed.
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Hepatitis C virus (HCV) infection poses significant global health challenges.
- Early diagnosis and treatment are crucial for managing HCV and preventing complications like hepatocellular carcinoma (HCC).
- Clinical decision-making in complex HCV cases can be difficult, necessitating a range of diagnostic tools.
Observation:
- A clinical case highlights diagnostic difficulties in a patient with a history of HCV infection.
- The patient presented with hepatocellular carcinoma after avoiding timely clinical follow-up for HCV.
- Non-invasive diagnostic procedures were insufficient to differentiate between hydatidosis and hepatocellular carcinoma in this case.
Findings:
- Hepatocellular carcinoma (HCC) developed in a patient with a history of hepatitis C virus (HCV) infection.
- Differential diagnosis between hydatidosis and HCC was not achievable through non-invasive methods.
- A liver biopsy was essential for achieving a definitive diagnosis in this complex clinical scenario.
Implications:
- This case underscores the importance of consistent patient follow-up for chronic hepatitis C virus (HCV) infection.
- It highlights the limitations of non-invasive diagnostic tools in differentiating certain liver pathologies, including HCC.
- Liver biopsy remains a criticalGold standard diagnostic procedure in challenging hepatobiliary disease cases.
More Related Videos
Related Concept Videos
Hepatitis
74
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
74
Viral Hepatitis I: Introduction
17
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
17
Esophageal Varices-II: Clinical Features and Management
872
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
872
Cirrhosis I: Introduction
23
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
23
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Diseases of the Liver and Gallbladder
2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K

